Comparison Chart EyeGene Inc.

Equities

End-of-day quote Korea S.E. Other stock markets 23:00:00 03/06/2024 BST			5-day change	1st Jan Change
2,850 ^KRW	+0.71%		-4.84%	-33.18%

2023	EyeGene Inc. announced that it has received KRW 15.000001688 billion in funding from BMI Korea Co., Ltd.	CI
2023	EyeGene Inc. announced that it expects to receive KRW 15.000001688 billion in funding from BMI Korea Co., Ltd.	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

		Sector	Change	5d. change	1st Jan change	1-year change	5-years change	Capi.	ST	MT	LT
	EYEGENE INC.	Other Pharmaceuticals	+0.71%	-4.84%	-33.18%	-39.10%	-71.97%	55.77M